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Receptor-interacting protein 140 (RIP140) is a corepressor of nuclear receptors that is highly expressed
in adipose tissues.We investigated the role of RIP140 in conditionally immortal preadipocyte cell lines
prepared from white or brown fat depots. In white adipocytes, a large set of brown fat-associated
geneswas up-regulated in the absenceof RIP140. In contrast, a relativelyminor role canbeascribed to
RIP140 in the control of basal gene expression in differentiated brown adipocytes because significant
changes were observed only in Ptgds and Fabp3. The minor role of RIP140 in brown adipocytes
correlates with the similar histology and uncoupling protein 1 and CIDEA staining in knockout com-
paredwithwild-type brown adipose tissue (BAT). In contrast, RIP140 knockout scwhite adipose tissue
(WAT) shows increased numbers of multilocular adipocytes with elevated staining for uncoupling
protein1andCIDEA. Furthermore inawhiteadipocyte cell line, themarkersofBRITEadipocytes, Tbx1,
CD137, Tmem26, Cited1, and Epsti1were repressed in the presence of RIP140 aswas Prdm16.Microar-
ray analysis of wild-type and RIP140-knockout white fat revealed elevated expression of genes asso-
ciated with cold-induced expression or high expression in BAT. A set of genes associated with a futile
cycle of triacylglycerol breakdown and resynthesis and functional assays revealed that glycerol kinase
and glycerol-3-phosphate dehydrogenase activity as well as [3H]glycerol incorporationwere elevated
in the absence of RIP140. Thus, RIP140blocks theBRITE program inWAT, preventing the expressionof
brown fat genes and inhibiting a triacylglycerol futile cycle, with important implications for energy
homeostasis. (Molecular Endocrinology 28: 344–356, 2014)
There are two types of adipose tissue with opposingfunctions: white adipose tissue (WAT) is associated
with dynamic energy storage, whereas brown adipose tis-
sue (BAT) is associated with energy expenditure (1).
White and brown adipocytes are often interspersed
within the same depot, and their relative amount deter-
mines the color of the depot (2). In mice, BAT is found
mainly in the interscapular depot whereas WAT is pre-
dominant in all other depots. However, cellular compo-
sition can change depending on the genetic background,
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sex, age, environmental temperature, and nutritional
status (3). Chronic exposure to cold, treatment with
3-adrenergic agonist, or overfeeding induces the devel-
opment of brown-like adipocytes (beige or BRITE adi-
pocytes) withinWAT,mainly in subcutaneous (sc) depots
(4). Although originally thought to be present only in
neonates, functional BAT has recently been identified in
adult humans (5). Because the thermogenic activity of
BAT mass is associated with protection against overnu-
trition and glucose intolerance (6) it is important to char-
acterize the regulators of the BAT-specific program.
Receptor-interacting protein 140 (RIP140) is a nuclear
receptor (NR) coregulator highly expressed in metabolic
and reproductive tissues (7). The physiological role of
RIP140 was indicated by the phenotype of RIP140-null
mice, which are lean with a 70% reduction in total body fat
mass and have higher oxygen consumption (8, 9). When
challenged with high-fat diet RIP140-knockout mice are re-
sistant to obesity and have increased insulin sensitivity and
glucose tolerance. They are also resistant to age- and diet-
induced hepatic steatosis, indicating that they do not use
alternative fat depots. Importantly, RIP140-null mice have
elevated expression of Ucp1 and carnitine palmitoyltrans-
ferase 1b (Cpt1b) in WAT, indicating that the lean pheno-
type is due to altered energy balance (8).
RIP140 was first identified as a cofactor that is re-
cruited to the estrogen receptor in presence of 17-estra-
diol (10). Subsequently, it was shown to interact with
nearly all the NRs and despite its ligand-dependent re-
cruitment, it usually acts to suppress their activity (7). In
WAT and muscle, RIP140 interacts with key NRs such as
peroxisome proliferator-activated receptors (PPARs),
thyroid hormone receptors, and estrogen-related recep-
tor (ERR) to suppress catabolic signaling pathways.
Expression analysis of differentiated adipocytes from
RIP140-null mouse embryo fibroblasts and from 3T3-L1
adipocytes depleted of RIP140, showed the up-regulation
of clusters of genes that are highly expressed in BAT,
including genes that are involved in mitochondrial bio-
genesis and function, energy dissipation, and catabolic
pathways (11, 12). Because many of these genes are tar-
gets of PPAR coactivator (PGC)-1 it seems that RIP140
and PGC-1 play mutually opposing roles.
In BAT, the role of RIP140 has not been fully elucidated.
However, its importance is implicated in newborn RIP140-
null mice that have reduced BAT mass, lower core body
temperature, and altered BAT gene expression (13). In
brown adipocytes, RIP140 is recruited to the Cidea pro-
moter through ERR and nuclear respiratory factor-1 (14).
In addition, RIP140 can suppress Ucp1 expression through
liver X receptor- in brown adipocytes by antagonizing the
binding of PPAR/PGC-1 to the Ucp1 promoter (15).
Due to the critical role of RIP140 in the control of
energy homeostasis, elucidating its role in the regulation
of WAT and BAT activity might provide new therapeutic
targets for obesity and diabetes. Here, we have found that
RIP140 has only a minor role in gene regulation in brown
adipocytes compared with its function in white adi-
pocytes, where it repressed genes associated with energy
utilization. Furthermore, a group of genes associatedwith
a futile cycle of TAG breakdown and resynthesis is con-
trolled by RIP140, highlighting an additional mechanism
for heat generation in adipose tissues.
Materials and Methods
Microarray analysis of gene expression
Total RNA was isolated from 3 samples each of RIPKO-1
and RIPKO-L cells after adipocyte differentiation (10 days).
Two RIP140-lentivirus-transduced cell lines were used for pro-
filing in order to avoid variation due to differences in the sites of
incorporation of the virus. For adipose tissue analysis, RNAwas
extracted from sc WAT of wild-type and RIP140/ 3-month-
old male mice maintained on standard chow. Mice used in this
studywere backcrossed 8 generations to C57BL/6J background.
All animal studies were carried out according to UK Home
Office guidelines.
Affymetrix array hybridization and scanning were per-
formed by the CSC/IC Microarray Centre, Imperial College
London, Hammersmith Campus, using Affymetrix MOE 430
v2.0 GeneChips. For the array on RNA from the cell lines, data
were analyzed with d-CHIP software (16). The microarray data
are available at http://www.ebi.ac.uk/arrayexpress/ under ac-
cession number E-MIMR-42.
For the array of wild-type and RIP140-knockout WAT ar-
ray, background correction, probe-level summarization and
normalization of raw data from Affymetrix CEL files were per-
formed across the full set of samples using Robust Multichip
Average (17) as implemented in the Affy package of Bioconduc-
tor. Genes with a significant difference in diet-based induction
between the wild-type and knock-out cell lines were identified
using LIMMA (18) to calculate empirical Bayes moderated t
statistics from a linear model evaluating the effect of diet in each
cell line. The Benjamini-Hochberg approach to multiple testing
adjustment was used to select a list of genes with a family-wise
error rate of 0.05. P values from the moderated t statistics were
used to rank the genes in terms of the significance of the differ-
ence between diet-induced change in expression between the
wild-type and knock-out cell lines.
For temperature and fat depot-specific expression, groups of
four 10-week-old female 129Sv mice (Charles River Laborato-
ries) were housed separately and kept at 22°C. Subsequently,
one group of mice was placed at 28°C and one groupwas placed
at 6°C for 10 days. Animals were housed and culled as previ-
ously reported (19) and adipose tissues (interscapular BAT and
sc, mesenteric, and gonadal WAT) were collected. Gene expres-
sion microarray was performed by Almac diagnostics UK using
GeneChip Mouse Genome 430A 2.0 Array (Affymetrix) on
RNA extracted from interscapular BAT and sc and mesenteric
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WAT from mice exposed to 28°C or 6°C. Three biological rep-
licates were used. The analysis was conducted using R program-
ming language and Bioconductor (20). After background ad-
justment, summarization, and normalization of the raw
intensities, the data were analyzed using affy (21) and limma
(22). Pair-wise comparisons between conditions were per-
formed. A linear model was fitted to the expression values of
each probe, modified to account for the replicated samples and
assuming no interaction between the genes. The moderated t
statistic was computed for each probe and for each contrast
providing P values that were corrected for multiple testing using
the Benjamini-Hochberg method to control the false discovery
rate (23). Probes with adjusted P values .01 were considered
statistically significant.
Light microscopy and immunohistochemistry
Serial paraffin sections, 3 m in thickness, were obtained
from each specimen. Some were stained with hematoxylin and
eosin to assess morphology; the others were used for immuno-
histochemistry. After dewaxing, antigen retrieval was achieved
with a pressure cooker treatment (90°C for 20minutes) by soak-
ing sections in a sodium citrate buffer 0.01 M, pH 6.0. After a
thorough rinse in PBS, sections were reacted with 0.3% H2O2
(in PBS; 30 minutes) to block endogenous peroxidase, rinsed
with PBS, and incubated in a 3% blocking solution (in PBS; 60
minutes). Then theywere incubatedwith the primary antibodies
(in PBS; overnight at 4°C). After a thorough rinse in PBS, sec-
tions were incubated in a 1:200 (vol/vol) biotinylated secondary
antibody solution in PBS for 30 minutes (goat antirabbit IgG;
Vector Laboratories). Histochemical reactions were performed
using Vectastain ABC kit (Vector Laboratories) and Sigma Fast
3,3 -diaminobenzidine (Sigma-Aldrich) as the substrate. Sec-
tionswere finally counterstainedwith hematoxylin, dehydrated,
and mounted in Entellan. The following primary antibodies
were used on serial sections: rabbit anti-uncoupling protein 1
(UCP1) (Abcam; catalog no. 10983 at diluition 1:600 [vol/vol])
and rabbit anti-Cidea (Sigma-Aldrich; catalog no. C7977 at di-
luition 1:100 [vol/vol]). Staining was never observed when the
primary antibody was omitted. Tissue sections were observed
with a Nikon Eclipse E800 light microscope (Nikon Instru-
ments) using different objectives, and digital images were cap-
tured with a Nikon DXM 1220 camera.
Generation of conditionally immortalized
preadipocyte cell lines
Primary cultures were prepared from sc WAT and interscap-
ular depots of RIP140/ and RIP140/ mice as described
previously (24). Preadipocytes were immortalized by retroviral-
mediated expression of temperature-sensitive SV40 large T-an-
tigen H-2kb-tsA58 (a gift from P. Jat). Cells were cultured at
33°C and selected with puromycin (5 g/mL). To differentiate
into adipocytes, they were grown to 90% confluence and then
cultured at 37°C. Theywere exposed, 48 hours after confluence,
to differentiation medium consisting of DMEM:F12 supple-
mented with 10% FBS, insulin (1 g/mL), dexamethasone (250
nM), isobutylmethylxanthine (0.5 mM), and rosiglitazone (2.5
nM). After 48 hours, the medium was replaced with fresh me-
dium supplemented with 10% FBS and insulin and cultured for
7–10 days.
Oil Red O staining
Oil Red O stain was used to confirm the presence of lipid in
cells. Cells were washed with PBS, fixed in 2% paraformalde-
hyde and 0.2% glutaraldehyde in PBS for 15 minutes, and then
rinsed with PBS. They were then stained with Oil Red O (in
isopropanol) for 20minutes and rinsed in 60% isopropanol and
then PBS.
Quantitative real-time PCR (Q-RT-PCR)
RNA extraction was performed with Trizol reagent (Invitro-
gen Life Technologies) according to manufacturer’s guidelines.
RNA (1 g) was used for cDNA synthesis according to the
manufacturer’s protocols using the Moloney murine leukemia
virus reverse transcriptase (Sigma) with random hexamers (In-
vitrogen) after treatment with deoxyribonuclease (Sigma). Syn-
thesized cDNAwas then used forQ-RT-PCR using SYBRGreen
I (Life Technologies) according to manufacturer’s instructions.
Thermocycling was performed on an ABI PRISM 7700 Se-
quence Detection System (Life Technologies). Fold changes
were calculated by the Ct method using L19 as a housekeep-
ing gene (25). PCR primers used in this study are listed in Sup-
plemental Table 1 published on The Endocrine Society’s Jour-
nals Online web site at http://mend.endojournals.org.
Reporter gene assay
Reporter assayswere carried out in 96-well plateswith 20 ng of
reporter gene and 5 ng of pRL-CMV, in the absence or presence of
PPAR (5 ng) or pEF-RIP140, using jetPRIME transfection re-
agent (Polyplus transfection) to transiently transfect 293 cells. The
Gyk luciferase promoter construct (2009/57 bp) (26) was pro-
videdbyM.Lazar. Luciferase activitywasmeasureusing Steadylite
Plus (PerkinElmer) and normalized to Renilla activity.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation assays were performed as
described previously (27). Briefly, 3T3-L1 adipocytes were fixed
with the protein-protein cross-linking reagent dimethyl adipimi-
date 2 HCl (Pierce Chemical Co.) at 10 mM in DMEM for 30
minutes followed by 1% formaldehyde in PBS for 10 minutes at
37°C. Harvested cells were then lysed, sonicated, and immuno-
precipitated with Protein A/G PLUS-agarose (Santa Cruz Bio-
technology, Inc.) according to the manufacturer’s instructions
using the following antibodies: RIP140 (a kind gift from Hon-
gwu Chen), PPAR (sc-7196; Santa Cruz Biotechnology), and
thyroid hormone receptor-associated protein 220/MED1 (sc-
5334; Santa Cruz). DNA fragments were purified with
QIAquick PCR purification kit (QIAGEN) and enrichment rel-
ative to input was determined by quantitative PCR. Primer se-
quences were taken from Reference 26.
Glycerol kinase enzymatic activity assay
Glycerol kinase (GYK) activity assay was performed as pre-
viously described (28) with minor modifications. Adipocytes
were differentiated until day 8 in 10-cm diameter culture dishes,
scraped on ice in 0.5 mL of glycerol kinase extraction buffer,
and freeze/thawed in liquid nitrogen to allow cell lysis. Cell
lysates were then centrifuged at 12 000 rpm for 15 minutes at
40°C, and protein concentration of the supernatant was deter-
mined by the Bradford assay. Protein (10 g) was then incu-
bated with 50 L assay buffer that included 5 mM ATP, 4 mM
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glycerol, and 500 M [3H]glycerol. The reaction was incubated
at 37°C, for 150 minutes and terminated with the addition of
100 L ethanol-methanol (97:3). [3H]glycerol was phosphory-
lated to [3H]glycerol-3-phosphate-dehydrogenase according to
the relative activity of GYK in each of the samples. Fifty micro-
liters of the reaction was then spotted onto DE-81 Whatman
filters (Whatman) which were air dried, washed in water under
a vacuum 5 times, and air-dried. Radioactivity adhering to the
filters was measured by liquid scintillation counting in 10 mL of
scintillant, corresponding to relative GYK activity.
Glycerol incorporation assay
Glycerol incorporation was adapted from previously pub-
lished protocols (28, 29) with minor modifications. Adipocytes
were differentiated until day 8 in 10-cm diameter culture dishes
serum starved for 3 hours in Kreb’s Ringer phosphate buffer
followed by a switch to normal differentiationmedium (DMEM
with 10% FBS and insulin), supplemented with 5 mM glucose,
100 Mglycerol, and 25 Ci [3H]glycerol and incubated for an
additional 2 hours at 37°C. The amount of labeled glycerol
incorporated into fat is directly proportional to the endogenous
GYK activity in metabolically active adipocytes. Total fat frac-
tions were isolated after cells were vigorously washed 3 times in
ice-cold PBS, collected with scraping in 0.25 mL of 0.2M NaCl
and freeze/thawed in liquid nitrogen. Once cells were lysed, 750
L of chloroform-methanol (2:1) was added to the thawed cell
suspension after which the mixture was vortex mixed and cen-
trifuged for 5 minutes at 6000  g. The top aqueous fraction
was discarded and the bottom lipid layer washed once with 1
mL of methanol-chloroform-water (48:3:47). [3H]Glycerol in-
corporated into these fat fractions was quantified by liquid scin-
tillation counting in vials containing 10 mL of scintillant.
Glycerol-3-phosphate-dehydrogenase enzymatic
activity assay
Glycerol-3-phosphate dehydrogenase (GPDH) activity was
evaluated using the GPDH activity assay kit (Takara; catalog
no. MK246) according to manufacturer’s instructions from
RIPKO-1 and RIPKO-L cells. Briefly, adipocytes were differen-
tiated until day 8 in 10-cm diameter culture dishes; a protein
extract was prepared using the kit’s enzyme extraction buffer
and equal amounts of protein for each sample in serial dilutions
were then incubated with substrate buffer containing dihy-
droxyacetone phosphate. The reaction was followed by moni-
toring the absorbance at 1-minute intervals for 10 minutes. The
relative GPDH activity was calculated according to the sug-
gested formula of the kit.
Triglyceride assay
Total cellular triglyceride levels in RIPKO-1 and RIPKO-L
cells were determinedwith the triglyceride colorimetric assay kit
(Cayman Chemical) according to the manufacturer’s instruc-
tions.Data was normalized to DNA content measured using
fluorescent DNA quantitation kit (Bio-Rad Laboratories).
Western blot
Protein levels of glycerol kinase and glycerol-3-phosphate
dehydrogenase were determined as described previously (27)
using the following antibodies: GYK (Abcam, ab20428) and
GPDH1 (Abcam, ab34492).
Results
RIP140 has been found, in WAT, to repress a set of genes
normally associated with BAT. However, its role in
brown adipocytes is less well defined. We generated con-
ditionally immortalized preadipocyte cell lines from both
BAT and WAT of mice heterozygous or null for the
NRIP1 gene. Heterozygous cells were selected for control
because heterozygous mice are phenotypically similar re-
garding body weight (13), and brown fat gene expression
was similar to that found in wild-type WAT and BAT
(Supplemental Figure 1A). Oil Red O staining showed
that all the cell lines differentiated efficiently following
treatment with a standard differentiation cocktail (Figure
1A) in agreement with previous analysis showing that
absence of RIP140 does not affect the ability of adi-
pocytes to fully differentiate (8, 11). The mRNA level of
genes highly expressed in white or brown adipocytes was
assessed in the different cell lines following differentia-
tion. The adipocyte marker Fabp4/aP2 was unaffected by
the absence or presence of RIP140. Genes that are nor-
mally expressed at high levels in brown fat were elevated
in the RIP140-null white adipocytes including Ucp1, Ci-
dea, Cpt1b, Bmp8b (Figure 1B). It is noteworthy that
RIP140 even repressed one of the key instigators of the
brown adipocyte program Prdm16. Surprisingly, very
few of the genes investigated were affected by the absence
of RIP140 in brown adipocytes. Strikingly, Ptgds, which
was elevated in the absence of RIP140 inwhite adipocytes
(60-fold), was also increased in the RIP140/ brown
adipocytes (30-fold) compared with RIP140-expressing
cells. The only other genes increased in the absence of
RIP140 in brown adipocytes were Cidea and Cpt1b and
only around 2-fold compared to 200-fold and 7-fold, re-
spectively, for these genes in white adipocytes. The minor
changes in brown adipocyte gene expression correlate
with the similar histologies and similar UCP1 and CIDEA
staining of BAT from wild-type and RIP140-null mice
(Supplemental Figure 2).
Although the basal levels of Ucp1 and PGC-1 were
unaffected by the absence of RIP140 in brown adipocytes,
the induction of these genes due to a 6-hour treatment
with the selective 3-adrenergic ligand CL 316,234 re-
sulted in significantly greater induction in cells lacking
RIP140 (Figure 1C). The levels of the 3-adrenergic re-
ceptor were similar in both genotypes and down-regu-
lated upon CL 316,234 treatment.
Ptgds showed the greatest increase in expression due to
RIP140 ablation in brown adipocytes of all genes moni-
tored. Because RIP140 functions to regulate NR activity
we investigated whether ligands for PPARs affected Ptgds
expression. The PPAR and PPAR ligands rosiglitazone
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and GW7647 did not affect Ptgds expression (data not
shown). Because we had previously found ERR to be
important for RIP140-dependent regulation of Ucp1 and
Cidea (14, 30), we tested whether the ERR inverse ago-
nist XCT790 could affect Ptgds expression. We found
that, in bothwhite and brown adipocytes lackingRIP140,
Figure 1. RIP140 repressed BAT genes in white adipocytes with only a minor role in brown adipocytes. A, Oil Red O stain of undifferentiated and
differentiated conditionally immortal preadipocyte cell lines derived from sc WAT and interscapular BAT from RIP140/ and / mice. B, The
expression of adipocyte genes in differentiated cells derived from brown (upper panel) or white fat (lower panel) was determined by Q-RT-PCR and
expressed relative to RIP140/ cells. *, P  .05, Student’s t test for comparison of RIP140/ vs / cells for expression of individual genes,
performed separately for brown and white cells. C, The expression of Ucp1, Ctp1b, PGC-1, and 3-AR was monitored in differentiated brown
adipocytes knockout () or heterozygous () for RIP140 in the absence and presence of 10 M CL 316,234 (CL) treatment for 5 hours. *, P 
.05, ANOVA with Bonferroni’s correction for differences in individual gene expression in RIP140-knockout and heterozygous cells, in the absence
and presence of CL. D, aP2 and Ptgds expression was determined by Q-RT-PCR in RIP140/ brown or white adipocytes in the absence and
presence of XCT790 (10 M). n.d. not detected. For Q-RT-PCR, relative means  SEM of biological triplicates are presented. *, P  .05, Student’s
t test for comparison of vehicle to XCT790.
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XCT790 potently repressed Ptgds mRNA expression
(Figure 1D).
Given that ablation of RIP140 resulted in the altered
expression of many more genes in white compared with
brown adipocytes and one of the affected genes was
Prdm16, which is considered to be important in the early
stages of brown adipocyte differentiation, we next fo-
cused on RIP140 and the BRITE program. Hematoxylin
and eosin staining showed a predominance of adipocytes
with multilocular morphology in RIP140 KO sc WAT
unlike the unilocular appearance in wild-type tissue (Fig-
ure 2A). Furthermore, the brown adipocyte/BRITEmark-
ers UCP1 and CIDEA showed greater expression in the
knockout tissue with most staining in the multilocular
cells (Figure 2A) in agreement with mRNA expression
(Supplemental Figure 1A). Next, we monitored the ex-
pression of the recently identified BRITE markers Tbx1,
CD137, Tmem26, Cited1, and Epsti1 (31, 32) and found
they were up-regulated in RIP140-null preadipocytes
(Figure 2B). Tle3, Ehmt1, and Tbl1xr1 (33–35) did not
show a statistically significant increase in expression in
the null cells. Because PGC-1 is a key regulator of brown
adipocyte/BRITE gene expression we monitored the lev-
els of its different transcripts (36). Total PGC-1, isoform
1, and isoform 4 were up-regulated in the absence of
RIP140, whereas isoforms 2 and 3 were not detectable in
either cell line (Figure 2B).
The genes Tbx1, CD137, and Tmem26 were down-
regulated in the WAT of a mouse model in which a
RIP140 transgene is overexpressed (Figure 2C) from a
-actin promoter (37). RIP140 mRNA and protein were
increased in the transgenic mouse (Figure 2B and Supple-
mental Figure 1B). Prdm16 levels were also reduced, as
was PGC-1 and Ucp1, in the presence of the RIP140
transgene. Taken together, these data indicate that
RIP140 represses the BRITE gene expression program in
WAT.
To investigate the action of RIP140 in white fat, we
performedmicroarray analysis using RNAprepared from
wild-type and RIP140-null WAT. We identified 736
probe sets to be significantly altered between the 2 geno-
types, with 510 up-regulated and 226 down-regulated
supporting a primary role as a corepressor in this tissue.
To further characterize the genes controlled by RIP140,
we compared the top 100 RIP140-repressed genes to gene
lists generated from a separate microarray analysis of
BAT, sc WAT, and mesenteric WAT from mice exposed
to either 28°C or 6°C for 10 days. Of the top 100 genes
repressed by RIP140, 65 were more highly expressed in
BAT compared with theWAT depots with 56 genes being
BAT-enriched compared with both sc and mesenteric
WAT (Table 1). From the analysis we could identify a set
of RIP140-regulated genes that were enriched in BAT
compared with WAT and cold regulated. Essentially, the
genes in this group are RIP140 targets in the BRITE pro-
gram and include Fabp3, Otop1, Pank1, Lipa, ERR,
Gyk, Kng1, PPAR, Pdk4, and Ptgds (Table 1).
It was surprising that the gene Gyk was repressed by
RIP140 because it is required for TAG synthesis and pre-
vious studies indicated that, in adipocytes, RIP140 was a
repressor of genes associated with catabolic rather than
anabolic processes. A clustering analysis of genes in-
volved in glycerol metabolism that are specifically up-
regulated in RIP140-null adipocytes is presented in Figure
3A. These include the glycerol phosphorylation enzyme
Gyk, the lipases Lipe, Pnpla2 and Ces3, the glycerol-spe-
cific membrane transporter aquaporin 7 (Aqp7), and the
glycerol-3-phosphate dehydrogenase enzymes 1 and 2
(Gpd1 and Gpd2). Expression of key rate-limiting en-
zymes of the TAG recycling mechanism on RNA from
independent adipocyte cells null for RIP140 (RIPKO-1)
and with lentiviral-mediated stable RIP140 expression
(RIPKO-L) was analyzed byQ-RT-PCR (Figure 3A). Gyk
showed 5-fold higher expression levels in RIP140-null
adipocytes, Lipe showed a 4.5-fold increase, whereas
Gpd1 and Gpd2 showed 3.3-fold and 5.6-fold increases,
respectively, confirming the microarray data. A similar
pattern was observed in sc white preadipocytes in which
Gyk, Gpd1, and Gpd2 were significantly up-regulated in
the absence of RIP140. Fabp3, Pank1, Aqp7, and the
lipase Ces3 were also increased in adipocytes knockout
for RIP140 (Figure 3B).
RIP140 repressed Gyk promoter-driven reporter gene
activity when cotransfected with PPAR (Figure 3C).
Chromatin immunoprecipitation showed that RIP140
was specifically bound to a PPAR response element
(PPRE) in the Gyk promoter and not detected in an up-
stream control region (Figure 3D). Furthermore, PPAR
and the coregulator MED1 were also found to be associ-
ated with the Gyk PPRE (Figure 3D). Western blotting
revealed that both GYK and GPD1 protein were ex-
pressed in adipocytes and not preadipocytes, and levels
were reduced when RIP140 was expressed (Figure 3E).
Finally, functional assays were undertaken to determine
the impact of RIP140 on glycerol metabolism. Glycerol
kinase activity, glycerol-3-phosphate dehydrogenase ac-
tivity, and [3H]glycerol incorporation into TAG were all
reduced in RIP140-expressing compared with null adi-
pocyte (Figure 3F). Furthermore, the total cellular TAG
levels were lower in the RIPKO cells (Figure 3F). Thus,
RIP140 inhibits the synthesis of TAG due to repression of
key genes required for the metabolism of glycerol.
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Discussion
In recent years there has been a renaissance in brown fat
research, given its identification in adult humans (5, 38).
BAT exists in a defined interscapular sc depot in mice
although brown adipocytes also exist within white-fat
depots. These BRITE cells are detected upon exposure to
stimuli such as cold. In adult humans, the detectable re-
gions of brown fat appear to be similar to the BRITE cells
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Figure 2. RIP140 suppresses the BRITE adipocyte program in white adipocytes. A, Hematoxylin and eosin (H & E) was performed on sc WAT from wild-
type (n	 5) and RIP140/ (KO) mice (n	 6) to asses morphology (top row). The tissue in KO mice disclosed the appearance of a higher number of
UCP1-positive multilocular adipocytes compared with wild type (middle row). The multilocular adipocytes were also positive for CIDEA, and the
expression was increased in KO mice (lower row). Scale bar, 200 m, applies to the top row, and 100 m applies to the remaining 4 images. B, Gene
expression was determined in undifferentiated sc white preadipocyte cell lines knockout or heterozygous for RIP140. Expression is presented relative to
RIP140/ cells. *, P .05 (Student’s t test) for comparison of RIP140/ vs / cells, for individual genes. C, Gene expression was determined in sc
WATs, wild type, or expressing a RIP140 transgene (TG). Expression is presented relative to wild type. For Q-RT-PCR, relative means SEM of biological
triplicates are presented. *, P .05 (Student’s t test) for comparison of wild-type vs transgenic for individual genes.
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(32). We determined RIP140 to be a regulator of the
BRITE program, with increased abundance of multilocu-
lar adipocytes and UCP1 and CIDEA-stained cells in sc
WAT of RIP140 KO. This was in contrast to the BAT,
which showed similar histology and staining when com-
pared with wild type. In white adipocytes mRNA expres-
sion of late-expressed markers such as Ucp1 as well as
early markers including Prdm16 (39), and Tbx1, CD137,
Tmem26 (31), Cited1, and Epsti1 (32) were elevated in
the absence of RIP140. Thus, RIP140 appears to have 2
distinct roles in adipocytes: 1) to repress regulators of the
BRITE program and 2) to repress genes expressed in dif-
ferentiated BRITE cells such as Ucp1 and Cidea (11).
A number of factors that switch white adipocytes to
express brown adipocyte genes have been identified in-
cluding PGC-1 (40), PRDM16 (41), and the myokine
irisin (42). The transcription factors and coregulators that
facilitate “browning” of white adipocytes have mostly
been studied in cell-based systems. RIP140 is a significant
player in this process because its absence in vivo, in white
fat, results in the induction of “brown fat” gene expres-
sion. Unlike the other regulators of the white-to-brown
switch RIP140 has a relatively minor role in brown adi-
pocytes. Its primary function in appears to be suppression
of the BRITE phenotype in white adipocytes. This may
involve stoichiometric inhibition of PGC-1-dependent
gene expression through promoter-boundNRs or a direct
interaction between these 2 coregulators (14). The ratio
of PGC-1 to RIP140 gene expression differs between
white and brown fat depots. The higher ratio is found in
mouse interscapular BAT compared with visceral and sc
WAT aswell as human BAT comparedwithWAT (43). In
addition, RIP140 may directly modulate expression of
PGC-1. We found PGC-1 isoforms 1 and 4, as well as
total PGC-1, were repressed by RIP140, and isoforms 2
and 3 were not detected in brown adipocytes. It is note-
worthy that although RIP140 has a minor transcriptional
role in brown adipocytes, it may have other important
roles, for example as a regulator of glucose trafficking
through interaction with AS160, which reduces the level
of AKT-dependent phosphorylation impeding its inacti-
vation, thus maintaining its inhibition of GLUT4 traffick-
ing (44).
The gene Ptgds, encoding for lipocalin prostaglandinD
synthase, stood out as induced following RIP140 ablation
in both brown and white adipocytes. We recently re-
ported that it controls fuel utilization in BAT because its
absence resulted in increased glucose utilization (45). In
the current study, we addressed the NRs that may deter-
mine the expression of Ptgds through coregulators such as
PGC-1 and RIP140. Although we found that Ptgds levels
were not affected by PPAR agonists, we did find that
ERR was required for its expression. Because ERR,
coregulated by PGC-1 and RIP140, is also important for
Ucp1 and Cidea expression (14, 46), the interplay be-
tween these 3 transcriptional regulators seems to be a
mechanism common to the regulation of many brown
adipocyte genes.
Most of the genes that are elevated in WAT due to
RIP140 ablation are more highly expressed in brown vs
white fat.We have identified RIP140-regulated genes that
are cold induced and associated with higher expression in
brown fat. This stringent data analysis highlights BRITE
genes that may be direct targets for RIP140 and include
Fabp3, Otop1, Pank1, Adrbk2, Kcnk3, Lipa, Errg, Gyk,
Igsf21, and Mcart1. Of these genes Gyk and Pank1 are
important in a TAG synthesis. This is somewhat surpris-
ing, given that RIP140, in adipocytes, has been linked
with suppression of energy utilization rather than ana-
bolic pathways. Furthermore, a clustering analysis of
RIP140-regulated genes in differentiated adipocytes re-
vealed additional up-regulated genes associatedwith both
TAG synthesis and breakdown. A futile cycle has been
reported in response to thiazolidinediones and PGC-1
and PPAR (28, 47) as well as due to cold stress in hu-
mans (48). This cycle of TAG hydrolysis and resynthesis
requires substantial amounts of ATP, because it is used
for the activation of free fatty acids by acyl-coenzyme A
C
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Figure 2. Continued.
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Table 1. RIP140 Represses the Expression of Genes Associated With the BRITE Adipocyte Program
Gene Symbol logFC adj.P.Val
Cold-Induced
(BAT)
Cold-Induced
(SC)
BAT-Enriched
(BAT vs SC)
BAT-Enriched
(BAT vs MES)
Fabp3 3.93 3.12E-03    
Otop1 2.83 5.27E-03    
Pank1 1.93 4.41E-03    
Adrbk2 1.79 2.40E-03    
Kcnk3 1.52 7.48E-04    
NA (Affy ID: 1441765_at) 1.47 1.53E-03    
Lipa 1.40 3.37E-05    
9030617O03Rik 1.35 3.47E-05    
Esrrg 1.15 8.99E-03    
Gyk 1.13 9.13E-04    
9230104K21Rik 1.13 2.26E-03    
Igsf21 1.08 4.26E-03    
Mcart1 1.00 1.96E-03    
Kng1 3.14 6.66E-07   
Pdk4 2.21 1.74E-03   
Slc25a42 2.15 2.22E-05   
Ppara 1.96 1.13E-03   
Acaa2 1.66 9.93E-04   
Tmem37 1.56 3.92E-03   
Pdk2 1.40 7.78E-04   
Tob2 1.38 1.38E-03   
Atp1a2 1.29 6.15E-05   
Oplah 1.18 4.12E-03   
Ccs 1.15 9.24E-05   
Itpk1 1.07 2.45E-03   
Crls1 1.07 5.27E-03   
Ptgds 2.58 1.03E-03   
4930506M07Rik 1.79 1.42E-04   
1700040L02Rik 1.71 1.26E-03   
Cad 1.49 5.05E-05   
Rgnef 1.04 1.35E-03   
Cdh2 1.81 5.85E-03  
Clic5 1.76 1.15E-03  
Peg3 1.64 5.85E-03  
Prelp 1.59 2.25E-03  
Acss1 1.46 4.42E-03  
Khdrbs3 1.43 4.75E-03  
NA (Affy ID: 1457444_at) 1.41 6.70E-04  
St6galnac6 1.37 3.55E-04  
Prkag2 1.29 2.44E-04  
Copg2as2 1.24 8.45E-03  
Ttc28 1.21 3.10E-04  
Heyl 1.21 6.96E-03  
Nfic 1.20 1.41E-04  
NA (Affy ID: 1442102_at) 1.18 2.26E-03  
Flot2 1.14 3.50E-05  
Cgnl1 1.09 2.25E-03  
Ccbl1 1.09 1.19E-04  
Trim2 1.08 9.67E-03  
Ttc28 1.05 5.06E-03  
Gmnn 1.04 3.45E-03  
NA (Affy ID: 1439477_at) 1.03 1.86E-03  
Npc1 1.03 4.35E-03  
Tmem109 1.02 4.88E-05  
2810055F11Rik 1.00 4.11E-04  
Psme3 1.00 1.15E-04  
Ttpa 1.58 3.01E-03  
Rarres2 1.37 1.91E-03  
Microarray analysis was performed on wild-type and RIP140 knockout WAT. Of the top 100 significantly RIP140-regulated genes, genes that were
up-regulated in the absence of RIP140 were categorized as induced in interscapular BAT or sc WAT from a microarray analysis of tissue from mice
exposed to 6°C vs 28°C. In addition, genes were categorized as BAT-enriched in BAT vs sc WAT or BAT vs mesenteric WAT, from mice maintained
at 28°C.
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Figure 3. RIP140 suppresses genes that control a futile cycle of TAG breakdown and resynthesis. A, Cluster analysis of gene expression in differentiated
RIPKO-1 and RIPKO-L cells as determined by Affymetrix microarray analysis. Gene expression for each sample is shown in columns; level of expression for
each gene across samples, along with each gene name, is shown in rows. The scale relating level of gene expression with color is shown with3 (bright
green) being low and3 (bright red) being high expression. Expression is relative to median levels of the 18 samples. Q-RT-PCR monitoring expression of
aP2, Gyk, Gpd1, Gpd2, and Lipe after differentiation in RIPKO-1 and RIPKO-L cells (upper left panel). Data are expressed relative to expression in RIPKO-1
cells. *, P .05 (Student’s t test) for comparison of RIPKO-1 vs RIPKO-L for individual genes. B, Expression of the indicated genes was determined in
RIP140/ and RIP140/ differentiated sc white adipocytes (lower panel). Data are expressed relative to expression in RIP140/ cells. *, P .05
(Student’s t test) for comparison of RIP140/ vs / cells for expression of individual genes. C, Transient transfection of 293 cells with Gyk promoter
reporter construct, or pGL2 Basic, in the absence and presence of PPAR and RIP140. Cells were treated with vehicle or 1 M rosiglitazone (Rosi). *, P
.05 (ANOVA) with Bonferroni’s correction for comparison of normalized luciferase activities in response to PPAR, RIP140, and ligand treatment, for
individual reporter constructs. D, Schematic representation of the Gyk gene indicating the position of the primers used for ChIP assay at the –2032-bp
enhancer element that encompasses a PPAR response element and an unrelated control region at4171 bp. ChIP assay using specific antibodies for
RIP140, PPAR, and Med1 in 3T3–L1 adipocytes for the Gyk enhancer and upstream control element. E, Western blots of whole-protein extracts from
RIPKO-1 andRIPKO-L preadipocytes and adipocytes probed with antibodies against GYK and GPD1. F, Relative GYK enzymatic activity in vitro
determined as [3H]glycerol phosphorylated to [3H]G3P in the presence of GYK isolated from RIPKO-1 and RIPKO-L adipocytes. Relative enzymatic activity
of GPD1 in vitro determined as decrease in NADH measured by absorbance in the presence of substrate and isolated GPD1 from RIPKO-1 and RIPKO-L
adipocytes. The incorporation of [3H]glycerol in isolated fat fractions from RIPKO-1, and RIPKO-L. Total cellular triglyceride levels were determined for
RIPKO-1 and RIPKO-L adipocytes. For Q-RT-PCR, reporter assays, and functional assays, means SEM of biological triplicates are presented. *, P .05
(Student’s t test) for comparison of RIPKO-1 vs RIPKO-L.
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(CoA) synthetases and for the phosphorylation of glyc-
erol by GYK (Figure. 4). The expression of GYK in adi-
pocytes allows for any glycerol that arises from increased
lipolysis to be phosphorylated to glycerol-3-phosphate
and recombined with free fatty acid to form TAG. Gyk
expression is primarily regulated by PPAR, and RIP140
represses the PPAR-dependent activation of the Gyk
promoter and binds directly to a previously reported
PPRE on its promoter. Moreover, the protein and relative
enzymatic activity of GYK is strikingly increased in
RIP140/ adipocytes, and the resulting phosphorylated
glycerol is incorporated into fat, confirming a futile cycle
of glycerol recycling.
Lipolysis could be elevated in the absence of RIP140
due to the increased expression of the adipocyte lipases
hormone-sensitive lipase and Ces3/ triacylglycerol (TAG)
hydrolase (49) (Figure 4). The adipose glycerol trans-
porter Aqp7 was induced in RIP140/ adipose tissue
and may be an important component of the futile cycle.
However, exactly how it would contribute to this cycle is
open to question because it is considered primarily an
exporter of glycerol. One possibility is that AQP7 func-
tions as a bidirectional glycerol pore that prevents the net
export of glycerol to enable sufficient glycerol levels for
TAG synthesis. This is supported by studies in Aqp7
knockout adipocytes in which [14C]glycerol uptake was
reduced by 3-fold comparedwithwild- type cells (50, 51).
Furthermore, in the presence of elevated Aqp7, in re-
sponse to pioglitazone or rosiglitazone in rodents, futile
cycling of TAG is maintained without increased release of
glycerol to the bloodstream (52, 53). It is likely that
RIP140 functions to repress Aqp7 expression via an in-
teraction with a PPAR because the Aqp7 promoter is reg-
ulated via a PPAR response element (52). PPARs are im-
portant targets for RIP140 in adipocytes (46), and
pantothenate kinase (Pank1) is a PPAR-regulated gene
(54) that we also found to be repressed by RIP140. It
catalyzes the first committed step and controls the overall
rate of CoA biosynthesis (55) and would facilitate the
high levels of acyl-CoA for TAG synthesis or -oxidation,
that would occur in activated brown or BRITE
adipocytes.
The expression of cytosolic and mitochondrial dehy-
drogenases Gpd1 and Gpd2 is also up-regulated in the
absence of RIP140. The activity and protein levels of
GPD1, which converts glucose and pyruvate-derived di-
hydroxyacetone phosphate to glucose-3-phosphate, are
increased in RIP140-null adipocytes although to a lesser
extent relative to GYK activity. The 2 glycerophosphate
dehydrogenases form the glycerol phosphate shuttle,
which provides for mitochondrial oxidation of reduced
nicotinamide adenine dinucleotide produced in the cyto-
plasm (56). The elevated expression of these enzymes
could reflect increased activity of the shuttle to accommo-
date increased glycolysis.
The futile cycle may be an important contributor to
Ucp1-independent thermogenesis during exposure to
cold. We found that Gyk and Aqp7, in addition to being
more highly expressed in brown compared with white
depots, were increased in WAT depots following cold
acclimatization (57). This cycle could provide unilocular
WAT cells with a thermogenic potential, which would be
completed with the increase in mitochondria number and
UCP1 levels acquired during their transdifferentiation
(19) to BRITE adipocytes. The viability of Ucp1-null mice
when exposed to the cold (4 or 5°C) reveals the presence
of alternative mechanisms, independent of UCP1, to
maintain body temperature (58–60). In fact, Ucp1-
knockout mice are still capable of exhibiting 50% of the
wild-type increase in maximal cold-induced heat produc-
tion. A futile cycle of TAG hydrolysis and resynthesis in
the adipose tissues of these mice could represent an im-
portant mechanism for heat generation and their survival
in the cold in the absence of UCP1.
The inappropriate expression of the BRITE phenotype
in WAT would drive excessive energy utilization and
therefore be a survival disadvantage. RIP140 can be as-
cribed to be a “thrifty gene” fulfilling this role by suppres-
sion of aspects of the brown/BRITE adipocyte phenotype.
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Figure 4. Schematic showing the TAG futile cycle under the control
of RIP140. A futile metabolic cycle of glycerol recycling is activated in
RIP140-null adipocytes. Asterisk indicates RIP140-regulated genes. The
induction of GYK and GPD1 in the absence of RIP140 allows for an
intracellular recycling of TAG, with breakdown followed by resynthesis
that utilizes energy and shifts the metabolic profile of adipocytes
toward energy expenditure. Lipolysis is facilitated by hormone-sensitive
lipase (HSL) and Carboxylesterase 3 (Ces3)/TAG hydrolase (TGH).
Pantothenate kinase 1 (PANK1) is a key regulatory enzyme in the
biosynthesis of CoA, FABP3 is a fatty acid transporter, and AQP7 is a
glycerol transporter.
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The RIP140-knockout mouse provides a novel genetic
model for BRITE adipocytes in white fat in the absence of
stimulus such as cold exposure. RIP140 represses genes
that 1) mediate a futile cycle of TAG breakdown and
resynthesis, 2) uncouple respiration and 3) are early
markers of the brown/BRITE program. Thus, RIP140
represents an important target for strategies to increase
the number of brown adipocytes within white fat depots.
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